Browsing UMB Coronavirus Publications by Title
Now showing items 378-397 of 637
|Nanocarrier vaccines for SARS-CoV-2 |
|A Nation-wide Review of Elective Surgery and COVID-Surge Capacity |
|National routine adult immunisation programmes among World Health Organization Member States: an assessment of health systems to deploy COVID-19 vaccines. |
|The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections |
|Navigating COVID-19 Testing: Special Considerations for the Cardiovascular Clinician |
|A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses |
|Next steps in long term care: How can nursing help? |
|Novel Insights Into Immune Systems of Bats |
|A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers |
|A Novel Stability-Indicating HPLC-DAD Method for Determination of Favipiravir, a Potential Antiviral Drug for COVID-19 Treatment; Application to Degradation Kinetic Studies and In-Vitro Dissolution Profiling |
|The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development |
|Nursing home visitation restrictions during COVID-19-Balancing compassion and safety |
|NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge. |
|Older Adults’ Intention to Socially Isolate Once COVID-19 Stay-at-Home Orders Are Replaced With “Safer-at-Home” Public Health Advisories: A Survey of Respondents in Maryland |
|On the Move or Barely Moving? Age-Related Changes in Physical Activity, Sedentary, and Sleep Behaviors by Weekday/Weekend Following Pandemic Control Policies. |
|One dose of COVID-19 nanoparticle vaccine REVC-128 provides protection against SARS-CoV-2 challenge at two weeks post immunization |
|One-Health: A safe, efficient, dual-use vaccine for humans and animals against middle east respiratory syndrome coronavirus and rabies virus |
|Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development. |
|Opportunities and Challenges in North-South and South-South Global Health Collaborations During the COVID-19 Pandemic: The AFREhealth-CUGH Experience (as Reported at the CUGH 2021 Satellite Meeting) |
|Optimal COVID-19 quarantine and testing strategies. |
The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.
By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.
To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.
After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.